Ultragenyx PharmaceuticalRARE
那斯達克 · USD
22.97
+0.18
(+0.79%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Ultragenyx PharmaceuticalRARE
22.97
+0.18
(+0.79%)
財務數據
損益表
- 1.27
- 1.09
- 1.47
- 1.39
- 1.65
- 1.39
- 1.67
- 1.60
- 2.07
- 1.36
- 29.92
- -14.57
- 35.09
- -5.12
- 18.20
- -15.69
- 19.99
- -3.94
- 29.60
- -34.39
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 136,000 | 207,279 | 159,933 | 166,788 | 139,000 | 164,877 | 139,494 | 147,026 | 108,833 | 127,392 |
營業成本 | 30,000 | 29,345 | 27,991 | 22,664 | 29,000 | 16,894 | 21,021 | 21,280 | 17,533 | 12,051 |
營業毛利 | 106,000 | 177,934 | 131,942 | 144,124 | 110,000 | 147,983 | 118,473 | 125,746 | 91,300 | 115,341 |
營業費用 | 275,000 | 291,217 | 302,832 | 251,951 | 253,000 | 270,261 | 250,460 | 242,107 | - | 237,390 |
研發費用 | 187,000 | 203,280 | 216,212 | 164,508 | 166,000 | 187,766 | 170,109 | 161,503 | 178,487 | 160,557 |
推銷及管理費用 | 88,000 | 87,937 | 86,620 | 87,443 | 87,000 | 82,495 | 80,351 | 80,604 | 78,160 | 76,833 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -169,000 | -113,283 | -170,890 | -107,827 | -143,000 | -122,278 | -131,987 | -116,361 | -165,347 | -122,049 |
其他收入及費用 | 6,000 | 5,578 | 4,820 | 8,602 | 7,668 | 5,944 | 13,808 | 5,572 | 7,219 | 10,596 |
利息費用 | 21,000 | 19,469 | 14,148 | 14,383 | 14,000 | 15,522 | 15,712 | 15,960 | 15,847 | 17,328 |
稅前純益 | -184,000 | -127,686 | -179,540 | -113,774 | -150,000 | -133,404 | -133,213 | -130,740 | -170,229 | -126,892 |
所得稅 | 1,000 | 870 | 873 | 1,257 | 1,000 | -19 | 303 | 858 | 455 | -3,702 |
稅後純益 | -185,000 | -128,556 | -180,413 | -115,031 | -151,000 | -133,385 | -133,516 | -131,598 | -170,684 | -123,190 |
基本每股稅後盈餘(元) | -1.84 | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 |
稀釋每股稅後盈餘(元) | -1.84 | -1.28 | -1.81 | -1.16 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 |
基本平均股數(千股) | 100600.00 | 99900.00 | 99771.00 | 98460.00 | 96300.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 |
稀釋平均股數(千股) | 100600.00 | 99900.00 | 99771.00 | 98460.00 | 96300.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 |
還原基本每股稅後盈餘(元) | -1.84 | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 |
還原稀釋每股稅後盈餘(元) | -1.84 | -1.28 | -1.81 | -1.16 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 |
還原基本平均股數(千股) | 100,600 | 99,900 | 99,771 | 98,460 | 96,300 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 |
還原稀釋平均股數(千股) | 100,600 | 99,900 | 99,771 | 98,460 | 96,300 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 |
EBITDA(千元) | -156,000 | -99,948 | -157,490 | -91,562 | -128,743 | -111,609 | -111,859 | -108,865 | -149,293 | -105,294 |